These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32821424)

  • 21. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
    BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Qualitative Study Exploring Contraceptive Practices and Barriers to Long-Acting Reversible Contraceptive Use in a Sample of Adolescents Living in the Southern United States.
    Coates C; Gordon CM; Simpson T
    J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):605-609. PubMed ID: 30012426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing Use of Long-Acting Reversible Contraception to Decrease Unplanned Pregnancy.
    Lotke PS
    Obstet Gynecol Clin North Am; 2015 Dec; 42(4):557-67. PubMed ID: 26598299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contraceptive Practices, Preferences, and Barriers Among Abortion Clients in North Carolina.
    Bryant AG; Speizer IS; Hodgkinson JC; Swiatlo A; Curtis SL; Perreira K
    South Med J; 2018 Jun; 111(6):317-323. PubMed ID: 29863217
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unintended pregnancy and subsequent postpartum long-acting reversible contraceptive use in Zimbabwe.
    Nance N; Ralph L; Padian N; Cowan F; Buzdugan R; Mushavi A; Mahomva A; McCoy SI
    BMC Womens Health; 2018 Nov; 18(1):193. PubMed ID: 30477497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends and regional variations in provision of contraception methods in a commercially insured population in the United States based on nationally proposed measures.
    Law A; Yu JS; Wang W; Lin J; Lynen R
    Contraception; 2017 Sep; 96(3):175-182. PubMed ID: 28596122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Midwives' experiences and views of giving postpartum contraceptive advice and providing long-acting reversible contraception: a qualitative study.
    McCance K; Cameron S
    J Fam Plann Reprod Health Care; 2014 Jul; 40(3):177-83. PubMed ID: 24500869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
    Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
    Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction.
    Hubacher D; Spector H; Monteith C; Chen PL
    Contraception; 2018 Jun; 97(6):524-532. PubMed ID: 29470950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perceived Barriers to Contraceptive Access and Acceptance among Reproductive-Age Women Receiving Opioid Agonist Therapy in Northeast Tennessee.
    Leinaar E; Brooks B; Johnson L; Alamian A
    South Med J; 2020 May; 113(5):213-218. PubMed ID: 32358615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
    Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
    Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods.
    Morse J; Freedman L; Speidel JJ; Thompson KM; Stratton L; Harper CC
    Perspect Sex Reprod Health; 2012 Jun; 44(2):100-6. PubMed ID: 22681425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationale and enrollment results for a partially randomized patient preference trial to compare continuation rates of short-acting and long-acting reversible contraception.
    Hubacher D; Spector H; Monteith C; Chen PL; Hart C
    Contraception; 2015 Mar; 91(3):185-92. PubMed ID: 25500324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring the physician's role in contraceptive counseling at the time of abortion in the US.
    Cannon R; White K; Seifert B; Woodhams E; Brandi K; Yinusa-Nyahkoon L
    Contraception; 2021 May; 103(5):316-321. PubMed ID: 33545128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.
    Hoopes AJ; Gilmore K; Cady J; Akers AY; Ahrens KR
    J Pediatr Adolesc Gynecol; 2016 Jun; 29(3):259-64. PubMed ID: 26477942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients' experiences with South Carolina's immediate postpartum Long-acting reversible contraception Medicaid policy.
    Mann ES; White AL; Rogers PL; Gomez AM
    Contraception; 2019 Aug; 100(2):165-171. PubMed ID: 31028752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.